1. Dahlin DC, Bertoni F, Beabout JW, Campanacci M. Fibrocartilaginous mesenchymoma with low-grade malignancy. Skeletal Radiol. 1984; 12:263–9.
Article
2. Gambarotti M, Righi A, Vanel D, et al. Fibrocartilaginous mesenchymoma of bone: a single-institution experience with molecular investigations and a review of the literature. Histopathology. 2017; 71:134–42.
Article
3. Saito T, Motoi T, Suehara Y, et al. Fibrocartilaginous mesenchymoma of the tibia with predominant microcystic features: a case report and literature review. Hum Pathol Case Rep. 2019; 16:100288.
Article
4. Bulychova IV, Unni KK, Bertoni F, Beabout JW. Fibrocartilagenous mesenchymoma of bone. Am J Surg Pathol. 1993; 17:830–6.
Article
5. Czerniak B. Dorfman and Czerniak’s bone tumors. 2nd ed. Philadelphia: Elsevier Saunders;2016. p. 606–14.
6. Bhaduri A, Deshpande RB. Fibrocartilagenous mesenchymoma versus fibrocartilagenous dysplasia: are these a single entity? Am J Surg Pathol. 1995; 19:1447–8.
7. Lin J, Shulman SC, Steelman CK, et al. Fibrocartilaginous mesenchymoma, a unique osseous lesion: case report with review of the literature. Skeletal Radiol. 2011; 40:1495–9.
Article
8. Fletcher CD. WHO classification of tumours of soft tissue and bone tumours. 5th ed. Lyon: IARC Press;2020. p. 470–1.